Style | Citing Format |
---|---|
MLA | Bidram Z, et al.. "Monastrol Derivatives: In Silico and in Vitro Cytotoxicity Assessments." Research in Pharmaceutical Sciences, vol. 15, no. 3, 2020, pp. 249-262. |
APA | Bidram Z, Sirous H, Khodarahmi GA, Hassanzadeh F, Dana N, Hariri AA, Rostami M (2020). Monastrol Derivatives: In Silico and in Vitro Cytotoxicity Assessments. Research in Pharmaceutical Sciences, 15(3), 249-262. |
Chicago | Bidram Z, Sirous H, Khodarahmi GA, Hassanzadeh F, Dana N, Hariri AA, Rostami M. "Monastrol Derivatives: In Silico and in Vitro Cytotoxicity Assessments." Research in Pharmaceutical Sciences 15, no. 3 (2020): 249-262. |
Harvard | Bidram Z et al. (2020) 'Monastrol Derivatives: In Silico and in Vitro Cytotoxicity Assessments', Research in Pharmaceutical Sciences, 15(3), pp. 249-262. |
Vancouver | Bidram Z, Sirous H, Khodarahmi GA, Hassanzadeh F, Dana N, Hariri AA, et al.. Monastrol Derivatives: In Silico and in Vitro Cytotoxicity Assessments. Research in Pharmaceutical Sciences. 2020;15(3):249-262. |
BibTex | @article{ author = {Bidram Z and Sirous H and Khodarahmi GA and Hassanzadeh F and Dana N and Hariri AA and Rostami M}, title = {Monastrol Derivatives: In Silico and in Vitro Cytotoxicity Assessments}, journal = {Research in Pharmaceutical Sciences}, volume = {15}, number = {3}, pages = {249-262}, year = {2020} } |
RIS | TY - JOUR AU - Bidram Z AU - Sirous H AU - Khodarahmi GA AU - Hassanzadeh F AU - Dana N AU - Hariri AA AU - Rostami M TI - Monastrol Derivatives: In Silico and in Vitro Cytotoxicity Assessments JO - Research in Pharmaceutical Sciences VL - 15 IS - 3 SP - 249 EP - 262 PY - 2020 ER - |